A clinical trial assessing INVA8001
Latest Information Update: 12 Dec 2022
At a glance
- Drugs INVA 8001 (Primary)
- Indications Systemic mastocytosis
- Focus Adverse reactions
Most Recent Events
- 12 Dec 2022 New trial record
Latest Information Update: 12 Dec 2022